HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Planned ORA Reorganization Could Move 100 Investigators To Field

This article was originally published in The Tan Sheet

Executive Summary

As many as 100 investigators will move to field positions as part of the proposed reorganization of FDA's Office of Regulatory Affairs, Commissioner Andrew von Eschenbach said April 12

You may also be interested in...



Bush Establishes Import Safety Group As Congress Grills FDA On Food Safety

President Bush established a working group July 18 to help guarantee the safety of food and other products shipped into the U.S

FDA’s Planned Lab Closings Draw More Questions From Congress

House Democrats are seeking to deny FDA funding to implement its plan to close seven field labs, saying the changes would "drastically undercut" the agency's food safety oversight capabilities

FDA Will Close Labs As Spending Is Locked At 2006 Levels

FDA plans to close laboratories across the United States, according to a Dec. 6 e-mail message from the Office of Regulatory Affairs

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138379

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel